Drug Development (Conference Announcement)

Antibiotic and Antiviral Compounds To Be Featured

Published in Hepatitis Weekly, January 10th, 2000

Late-stage antibacterial compounds in clinic will be featured at the Fifth International Antibacterial Drug Discovery & Development Summit, to be held on March 13-14, 2000, in Princeton, New Jersey, announced the conference sponsor Strategic Research Institute.

A conference on the newest advances by the pharmaceutical industry in developing novel drugs to fight viral diseases, including respiratory/influenza, HIV, and hepatitis B and C, will follow on March 15-16.

The international conference will feature promising antibacterial clinical agents including oxazolidinones, glycylcyclines, beta-lactamases, carbapenems, quinolones, ketolides,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly

Source: Hepatitis Weekly (2000-01-10)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry